According to the National Health Commission, the figure also includes elderly and teenagers between 12 and 17 years of age.
Although the proportion of those vaccinated is close to the 80 percent target set by China for herd immunity, authorities plan to further promote the benefits of the campaign and will open new centers to reach more individuals.
China uses its own medicines and applied more than two billion doses to national and foreign citizens as a whole.
Pharmaceutical companies such as Sinopharm and Sinovac are considering administering a reinforcement to the elderly, health workers and other sectors considered vulnerable, in view of the circulation of more dangerous variants of the SARS-CoV-2 coronavirus such as Delta.
China has accumulated at least 5,685 deaths and 123,285 cases in its mainland, Hong Kong, Macao and Taiwan since the emergence of the pathology and the virus that causes it in December 2019.
Apart from that, it has 401 asymptomatic patients under medical care.